Jon E. Angell

Array ( [id] => 7448918 [patent_doc_number] => 20040009941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Microspheres and adjuvants for DNA vaccine delivery' [patent_app_type] => new [patent_app_number] => 10/420482 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11157 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009941.pdf [firstpage_image] =>[orig_patent_app_number] => 10420482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834745 [patent_doc_number] => 20030162291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Clk-2, cex-7 and coq-4 genes, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/312187 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 10550 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162291.pdf [firstpage_image] =>[orig_patent_app_number] => 10312187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135994 [patent_doc_number] => 20040043930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 10/403161 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 138810 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043930.pdf [firstpage_image] =>[orig_patent_app_number] => 10403161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740768 [patent_doc_number] => 20030158137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Gene directed enzyme prodrug theraphy (gdept) for cell ablation' [patent_app_type] => new [patent_app_number] => 10/258760 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5258 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158137.pdf [firstpage_image] =>[orig_patent_app_number] => 10258760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797089 [patent_doc_number] => 20030175963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Platform for the differentiation of cells' [patent_app_type] => new [patent_app_number] => 10/386759 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6131 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175963.pdf [firstpage_image] =>[orig_patent_app_number] => 10386759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152467 [patent_doc_number] => 08168776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Method for making a 21 nucleotide double stranded RNA chemically linked at one end' [patent_app_type] => utility [patent_app_number] => 10/382768 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6121 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168776.pdf [firstpage_image] =>[orig_patent_app_number] => 10382768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710460 [patent_doc_number] => 20030170209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization' [patent_app_type] => new [patent_app_number] => 10/169180 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6999 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170209.pdf [firstpage_image] =>[orig_patent_app_number] => 10169180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448890 [patent_doc_number] => 20040009939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Methods of enhancing immune induction involving MDA-7' [patent_app_type] => new [patent_app_number] => 10/378590 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 58618 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009939.pdf [firstpage_image] =>[orig_patent_app_number] => 10378590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591142 [patent_doc_number] => 07662948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Antisense oligonucleotides against VR1' [patent_app_type] => utility [patent_app_number] => 10/376341 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10326 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662948.pdf [firstpage_image] =>[orig_patent_app_number] => 10376341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7148007 [patent_doc_number] => 20040170605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications' [patent_app_type] => new [patent_app_number] => 10/375715 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10582 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170605.pdf [firstpage_image] =>[orig_patent_app_number] => 10375715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711575 [patent_doc_number] => 20030171324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Regulation of human desc1-like serine protease' [patent_app_type] => new [patent_app_number] => 10/332122 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17829 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171324.pdf [firstpage_image] =>[orig_patent_app_number] => 10332122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6844648 [patent_doc_number] => 20030149995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Compound screening methods' [patent_app_type] => new [patent_app_number] => 10/371101 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149995.pdf [firstpage_image] =>[orig_patent_app_number] => 10371101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436289 [patent_doc_number] => 20040002472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Vaccination or immunization using a prime-boost regimen' [patent_app_type] => new [patent_app_number] => 10/368879 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24464 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002472.pdf [firstpage_image] =>[orig_patent_app_number] => 10368879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822089 [patent_doc_number] => 20030220250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Angiopoietin-1 in the treatment of disease' [patent_app_type] => new [patent_app_number] => 10/367259 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36968 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220250.pdf [firstpage_image] =>[orig_patent_app_number] => 10367259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92202 [patent_doc_number] => 07732402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Mammalian telomerase' [patent_app_type] => utility [patent_app_number] => 10/359935 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22107 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732402.pdf [firstpage_image] =>[orig_patent_app_number] => 10359935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809063 [patent_doc_number] => 20030199002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Clk-2 nucleic acids, polypeptides and uses thereof' [patent_app_type] => new [patent_app_number] => 10/349507 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 54342 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199002.pdf [firstpage_image] =>[orig_patent_app_number] => 10349507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6661231 [patent_doc_number] => 20030135875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Models of chronic and acute inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/349464 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10763 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20030135875.pdf [firstpage_image] =>[orig_patent_app_number] => 10349464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710951 [patent_doc_number] => 20030170700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Secreted and cell surface polypeptides affected by cholesterol and uses thereof' [patent_app_type] => new [patent_app_number] => 10/340192 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28771 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170700.pdf [firstpage_image] =>[orig_patent_app_number] => 10340192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363520 [patent_doc_number] => 07482332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Telomere-encoding synthetic DNA nanocircles, and their use for the elongation of telomere repeats' [patent_app_type] => utility [patent_app_number] => 10/336265 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 14763 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482332.pdf [firstpage_image] =>[orig_patent_app_number] => 10336265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 195950 [patent_doc_number] => 07635687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Vector system' [patent_app_type] => utility [patent_app_number] => 10/334235 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 30 [patent_no_of_words] => 25003 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635687.pdf [firstpage_image] =>[orig_patent_app_number] => 10334235 [rel_patent_id] =>[rel_patent_doc_number] =>)